ここから本文です

July 23 (Reuters) - The U.S. Food and Drug Administration approved Samsung Bioepis Co Ltd's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the health agency said on Tuesday.決算前にこれですか